MetaCap

Capricor Therapeutics Insider Trades

NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.59+0.06 (+0.80%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
13 · $8.37M
Shares bought / sold
0 / 272.53K
Net activity
Net selling $8.4 million

Capricor Therapeutics insider activity

Over the last 12 months, Capricor Therapeutics insiders reported 32 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $8.4 million worth of stock, for net insider selling of $8.4 million. The largest seller was Sabar Karimah Es, with $3.8 million in reported sales.

The most recent filing shows Krasney Karen (EVP, GENERAL COUNSEL) reporting a transaction in 24,100 shares at $3.18 on Jun 25, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAPR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CAPR insider transactions

Capricor Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jun 25, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSale24,100$732.16KForm 4
Jun 25, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise24,100$76.64KForm 4
Jun 25, 2026Krasney KarenEVP, GENERAL COUNSELSale24,100$732.16KForm 4
Jun 25, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise24,100$76.64KForm 4
Jun 24, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSale400$12.00KForm 4
Jun 24, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise400$1.27KForm 4
Jun 24, 2026Krasney KarenEVP, GENERAL COUNSELSale400$12.00KForm 4
Jun 24, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise400$1.27KForm 4
Jun 22, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSale500$15.00KForm 4
Jun 22, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise500$1.59KForm 4
Jun 22, 2026Krasney KarenEVP, GENERAL COUNSELSale500$15.00KForm 4
Jun 22, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise500$1.59KForm 4
May 18, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise3,000$4.17KForm 4
May 13, 2026Litvack FrankDirectorOption exercise3,937$5.47KForm 4
May 1, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSale25,000$792.54KForm 4
May 1, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise25,000$79.50KForm 4
May 1, 2026Krasney KarenEVP, GENERAL COUNSELSale25,000$792.55KForm 4
May 1, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise25,000$79.50KForm 4
Apr 2, 2026Sabar Karimah EsDirectorSale7,529$240.93KForm 4
Apr 2, 2026Sabar Karimah EsDirectorOption exercise7,529$23.94KForm 4
Apr 1, 2026Sabar Karimah EsDirectorSale53,735$1.67MForm 4
Apr 1, 2026Sabar Karimah EsDirectorOption exercise53,735$261.15KForm 4
Mar 31, 2026Krasney KarenEVP, GENERAL COUNSELSale25,000$752.93KForm 4
Mar 31, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise2,819$8.96KForm 4
Mar 31, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise21,488$80.37KForm 4
Mar 31, 2026Krasney KarenEVP, GENERAL COUNSELOption exercise693$963.27Form 4
Mar 31, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSale25,000$753.15KForm 4
Mar 31, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise25,000$79.50KForm 4
Mar 31, 2026Sabar Karimah EsDirectorSale61,265$1.85MForm 4
Mar 31, 2026Sabar Karimah EsDirectorOption exercise61,265$297.75KForm 4
Dec 30, 2025Krasney KarenEVP, GENERAL COUNSELOption exercise2,500$3.48KForm 4
Dec 19, 2025DUNBAR GEORGE W JRDirectorOption exercise3,000$4.17KForm 4
Mar 5, 2025Marban LindaCHIEF EXECUTIVE OFFICERother12,500—Form 4
Mar 3, 2025Bergmann AnthonyCHIEF FINANCIAL OFFICEROption exercise2,500$3.48KForm 4
Mar 3, 2025DUNBAR GEORGE W JRDirectorOption exercise750$1.04KForm 4
Mar 3, 2025Litvack FrankDirectorTax withholding2,543$34.76KForm 4
Mar 3, 2025Litvack FrankDirectorOption exercise25,000$34.75KForm 4
Mar 3, 2025Marban LindaCHIEF EXECUTIVE OFFICEROption exercise25,000$34.75KForm 4
Feb 27, 2025COLLIER EARL M JRDirectorOption exercise750$1.04KForm 4
Jan 2, 2025Bergmann AnthonyCHIEF FINANCIAL OFFICERAward3,342—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related